Emyria delighted to be accepted into prestigious US pain initiative
- Written by The Bulletin
Melbourne, Victoria - News Direct - 30 November 2022 -
Emyria Ltd (ASX:EMD) Michael Winlo tells Proactive the company has been accepted into the US National Institute of Health's (NIH) Preclinical Screening Platform for Pain program.
Read more: Emyria delighted to be accepted into prestigious US pain initiative
